Inflammation as a Target in Cancer Therapy

Por Sonia Leon-Cabrera, Kathryn L. Schwertfeger, Luis I. Terrazas
Publicado em 2019-01-01

The Content and Size of Hyaluronan in Biological Fluids and Tissues

Por Mary K. Cowman, Hong-Gee eLee, Kathryn L. Schwertfeger, James B. McCarthy, Eva A. Turley
Publicado em 2015-06-01

Building bridges toward invasion: tumor promoter treatment induces a novel protein kinase C-dependent phenotype in MCF10A mammary cell acini.

Por Kristine S Klos, Janel K Warmka, Disa M Drachenberg, Liang Chang, G W Gant Luxton, Cheuk T Leung, Kathryn L Schwertfeger, Elizabeth V Wattenberg
Publicado em 2014-01-01

Posttranslationally modified progesterone receptors direct ligand-specific expression of breast cancer stem cell-associated gene programs

Por Todd P. Knutson, Thu H. Truong, Shihong Ma, Nicholas J. Brady, Megan E. Sullivan, Ganesh Raj, Kathryn L. Schwertfeger, Carol A. Lange
Publicado em 2017-04-01

Erratum: Witschen, P.M., et al. Tumor Cell Associated Hyaluronan-CD44 Signaling Promotes Pro-Tumor Inflammation in Breast Cancer. <i>Cancers</i> 2020, <i>12</i>, 1325

Por Patrice M. Witschen, Thomas S. Chaffee, Nicholas J. Brady, Danielle N. Huggins, Todd P. Knutson, Rebecca S. LaRue, Sarah A. Munro, Lyubov Tiegs, James B. McCarthy, Andrew C. Nelson, Kathryn L. Schwertfeger
Publicado em 2020-09-01

Tumor Cell Associated Hyaluronan-CD44 Signaling Promotes Pro-Tumor Inflammation in Breast Cancer

Por Patrice M. Witschen, Thomas S. Chaffee, Nicholas J. Brady, Danielle N. Huggins, Todd P. Knutson, Rebecca S. LaRue, Sarah A. Munro, Lyubov Tiegs, James B. McCarthy, Andrew C. Nelson, Kathryn L. Schwertfeger
Publicado em 2020-05-01